{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:48:30Z","timestamp":1792547310874,"version":"4.5.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-01977-3","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T05:37:18Z","timestamp":1773121038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Progress in research on the effects of Platelet-Rich Plasma (PRP) ovarian injection on early ovarian reserve dysfunction and premature ovarian insufficiency"],"prefix":"10.1186","volume":"19","author":[{"given":"Min","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangdan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanna","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"1977_CR1","doi-asserted-by":"publisher","first-page":"1374382","DOI":"10.3389\/fendo.2024.1374382","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Li J, Lu W, Gao F, Zhang S, Li J. Therapeutic roles of platelet-rich plasma to restore female reproductive and endocrine dysfunction. Front Endocrinol (Lausanne). 2024;15:1374382. https:\/\/doi.org\/10.3389\/fendo.2024.1374382.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1977_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cytogfr.2021.11.003","volume":"64","author":"E Cecerska-Hery\u0107","year":"2021","unstructured":"Cecerska-Hery\u0107 E, Goszka M, Serwin N, et al. Applications of the regenerative capacity of platelets in modern medicine. Cytokine Growth Factor Rev. 2021;64:84\u201394. https:\/\/doi.org\/10.1016\/j.cytogfr.2021.11.003.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"1977_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/17474086.2021.1860002","volume":"14","author":"S Gupta","year":"2021","unstructured":"Gupta S, Paliczak A, Delgado D. Evidence-based indications of platelet-rich plasma therapy. Expert Rev Hematol. 2021;14(1):97\u2013108. https:\/\/doi.org\/10.1080\/17474086.2021.1860002.","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"1977_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ejp.1846","volume":"26","author":"Y Bohren","year":"2022","unstructured":"Bohren Y, Timbolschi DI, Muller A, Barrot M, Yalcin I, Salvat E. Platelet-rich plasma and cytokines in neuropathic pain: A narrative review and a clinical perspective. Eur J Pain. 2022;26(1):43\u201360. https:\/\/doi.org\/10.1002\/ejp.1846.","journal-title":"Eur J Pain"},{"issue":"9","key":"1977_CR5","doi-asserted-by":"publisher","first-page":"e28998","DOI":"10.7759\/cureus.28998","volume":"14","author":"J Varghese","year":"2022","unstructured":"Varghese J, Acharya N. Platelet-Rich plasma: A promising regenerative therapy in gynecological disorders. Cureus. 2022;14(9):e28998. https:\/\/doi.org\/10.7759\/cureus.28998.","journal-title":"Cureus"},{"issue":"6","key":"1977_CR6","doi-asserted-by":"publisher","first-page":"e86968","DOI":"10.7759\/cureus.86968","volume":"17","author":"J Zhang","year":"2025","unstructured":"Zhang J. From adhesions to conception: A case study on Platelet-Rich plasma\u2019s role in gynecologic recovery. Cureus. 2025;17(6):e86968. https:\/\/doi.org\/10.7759\/cureus.86968.","journal-title":"Cureus"},{"issue":"10","key":"1977_CR7","doi-asserted-by":"publisher","first-page":"e47239","DOI":"10.7759\/cureus.47239","volume":"15","author":"S Safarova","year":"2023","unstructured":"Safarova S, Cevher Akdulum MF, Guler I, Bozkurt N, Erdem A, Karabacak RO. Does Platelet-Rich plasma treatment increase in vitro fertilization (IVF) success in the infertile population? Cureus. 2023;15(10):e47239. https:\/\/doi.org\/10.7759\/cureus.47239.","journal-title":"Cureus"},{"issue":"1","key":"1977_CR8","doi-asserted-by":"publisher","first-page":"hox001","DOI":"10.1093\/hropen\/hox001","volume":"2017","author":"RA Anderson","year":"2017","unstructured":"Anderson RA, Wallace WHB, Telfer EE. Ovarian tissue cryopreservation for fertility preservation: clinical and research perspectives. Hum Reprod Open. 2017;2017(1):hox001.","journal-title":"Hum Reprod Open"},{"issue":"1","key":"1977_CR9","doi-asserted-by":"publisher","first-page":"103940","DOI":"10.1016\/j.rbmo.2024.103940","volume":"49","author":"N S\u00e4nger","year":"2024","unstructured":"S\u00e4nger N, John J, Einenkel R, Schallmoser A. First report on successful delivery after retransplantation of vitrified, rapid-warmed ovarian tissue in Europe. Reprod Biomed Online. 2024;49(1):103940.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"1977_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12958-025-01388-x","volume":"23","author":"NLA Emrich","year":"2025","unstructured":"Emrich NLA, Einenkel R, F\u00e4rber CM, Schallmoser A, S\u00e4nger N. Ovarian tissue cryopreservation for fertility preservation: a two-decade single-center experience with 451 children and adolescents. Reprod Biol Endocrinol. 2025;23(1):51.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"1977_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.fertnstert.2024.11.007","volume":"123","author":"N Panay","year":"2025","unstructured":"Panay N, Anderson RA, et al. Evidence-based guideline: premature ovarian insufficiency. Fertil Steril. 2025;123(2):221\u201336. https:\/\/doi.org\/10.1016\/j.fertnstert.2024.11.007.","journal-title":"Fertil Steril"},{"key":"1977_CR12","doi-asserted-by":"publisher","unstructured":"Vogt EC, Russell HNB, \u00d8ksnes M, Lund A. Premature ovarian insufficiency. Tidsskr nor Laegeforen. 2022;142(11). https:\/\/doi.org\/10.4045\/tidsskr.21.0675.","DOI":"10.4045\/tidsskr.21.0675"},{"issue":"1","key":"1977_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13104-024-06802-y","volume":"17","author":"B Havl\u00ednov\u00e1","year":"2024","unstructured":"Havl\u00ednov\u00e1 B, Sou\u010dkov\u00e1 I, Kop\u0159ivov\u00e1 K, Dole\u017eal J. Potential clinical application of anti-M\u00fcllerian hormone testing in radioiodine treatment of thyroid carcinoma. BMC Res Notes. 2024;17(1):147. https:\/\/doi.org\/10.1186\/s13104-024-06802-y.","journal-title":"BMC Res Notes"},{"key":"1977_CR14","doi-asserted-by":"publisher","DOI":"10.1039\/d5ay00658a","author":"Y Sun","year":"2025","unstructured":"Sun Y, Zhang YY, Liu XT, et al. High-efficiency chemiluminescent POCT assay for anti-M\u00fcllerian hormone: innovative development and application in polycystic ovary syndrome diagnosis. Anal Methods. 2025. https:\/\/doi.org\/10.1039\/d5ay00658a.","journal-title":"Anal Methods"},{"issue":"2","key":"1977_CR15","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1530\/REP-21-0022","volume":"162","author":"SU Park","year":"2021","unstructured":"Park SU, Walsh L, Berkowitz KM. Mechanisms of ovarian aging. Reproduction. 2021;162(2):R19\u201333. https:\/\/doi.org\/10.1530\/REP-21-0022.","journal-title":"Reproduction"},{"issue":"1","key":"1977_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12902-021-00706-9","volume":"21","author":"AN Serin","year":"2021","unstructured":"Serin AN, Birge \u00d6, Uysal A, G\u00f6rar S, Tekeli F. Hashimoto\u2019s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-M\u00fcllerian hormone levels. BMC Endocr Disord. 2021;21(1):44. https:\/\/doi.org\/10.1186\/s12902-021-00706-9.","journal-title":"BMC Endocr Disord"},{"key":"1977_CR17","doi-asserted-by":"publisher","first-page":"100435","DOI":"10.1016\/j.coemr.2023.100435","volume":"28","author":"E Kapoor","year":"2023","unstructured":"Kapoor E. Premature ovarian insufficiency. Curr Opin Endocr Metab Res. 2023;28:100435. https:\/\/doi.org\/10.1016\/j.coemr.2023.100435.","journal-title":"Curr Opin Endocr Metab Res"},{"key":"1977_CR18","doi-asserted-by":"publisher","first-page":"e077469","DOI":"10.1136\/bmj-2023-077469","volume":"384","author":"Z Nash","year":"2024","unstructured":"Nash Z, Davies M. Premature ovarian insufficiency. BMJ. 2024;384:e077469. https:\/\/doi.org\/10.1136\/bmj-2023-077469.","journal-title":"BMJ"},{"issue":"22","key":"1977_CR19","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.3390\/jcm10225247","volume":"10","author":"MM Dolmans","year":"2021","unstructured":"Dolmans MM, Hossay C, Nguyen TYT, Poirot C. Fertility preservation: how to preserve ovarian function in Children, adolescents and adults. J Clin Med. 2021;10(22):5247. https:\/\/doi.org\/10.3390\/jcm10225247.","journal-title":"J Clin Med"},{"issue":"4","key":"1977_CR20","doi-asserted-by":"publisher","first-page":"hoae065","DOI":"10.1093\/hropen\/hoae065","volume":"2024","author":"N Panay","year":"2024","unstructured":"Panay N, Anderson RA, Bennie A, et al. Evidence-based guideline: premature ovarian insufficiency. Hum Reprod Open. 2024;2024(4):hoae065. https:\/\/doi.org\/10.1093\/hropen\/hoae065.","journal-title":"Hum Reprod Open"},{"issue":"4","key":"1977_CR21","doi-asserted-by":"publisher","first-page":"699","DOI":"10.5603\/EP.a2022.0061","volume":"73","author":"MF Cevher Akdulum","year":"2022","unstructured":"Cevher Akdulum MF, Erdem M, Barut G, et al. The relationship between thyroid autoimmunity and poor response to ovarian stimulation in in vitro fertilization women with infertility. Endokrynol Pol. 2022;73(4):699\u2013705. https:\/\/doi.org\/10.5603\/EP.a2022.0061.","journal-title":"Endokrynol Pol"},{"issue":"18","key":"1977_CR22","doi-asserted-by":"publisher","first-page":"10115","DOI":"10.3390\/ijms251810115","volume":"25","author":"G Demyashkin","year":"2024","unstructured":"Demyashkin G, Vadyukhin M, Murtazalieva Z, et al. Novel molecular mechanisms underlying the ameliorative effect of Platelet-Rich plasma against electron Radiation-Induced premature ovarian failure. Int J Mol Sci. 2024;25(18):10115. https:\/\/doi.org\/10.3390\/ijms251810115.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1977_CR23","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1080\/15376516.2022.2057264","volume":"32","author":"H Aboutalebi","year":"2022","unstructured":"Aboutalebi H, Alipour F, Ebrahimzadeh-Bideskan A. The protective effect of co-administration of platelet-rich plasma (PRP) and Pentoxifylline (PTX) on cyclophosphamide-induced premature ovarian failure in mature and immature rats. Toxicol Mech Methods. 2022;32(8):588\u201396. https:\/\/doi.org\/10.1080\/15376516.2022.2057264.","journal-title":"Toxicol Mech Methods"},{"issue":"1","key":"1977_CR24","doi-asserted-by":"publisher","first-page":"e12666","DOI":"10.1002\/rmb2.12666","volume":"24","author":"Z Guo","year":"2025","unstructured":"Guo Z, Kawamura K. Ovarian function restoration using autologous Platelet-Rich plasma. Reprod Med Biol. 2025;24(1):e12666. https:\/\/doi.org\/10.1002\/rmb2.12666.","journal-title":"Reprod Med Biol"},{"key":"1977_CR25","doi-asserted-by":"publisher","unstructured":"Wang J, Zhao Y, Zheng F, et al. Activated human umbilical cord blood Platelet-Rich plasma enhances the beneficial effects of human umbilical cord mesenchymal stem cells in Chemotherapy-Induced POF rats. Stem Cells Int. 2021;8293699. https:\/\/doi.org\/10.1155\/2021\/8293699.","DOI":"10.1155\/2021\/8293699"},{"issue":"4","key":"1977_CR26","doi-asserted-by":"publisher","first-page":"C44","DOI":"10.1530\/RAF-22-0078","volume":"3","author":"ES Sills","year":"2022","unstructured":"Sills ES, Wood SH. Epigenetics, ovarian cell plasticity, and platelet-rich plasma: mechanistic theories. Reprod Fertil. 2022;3(4):C44\u201351. https:\/\/doi.org\/10.1530\/RAF-22-0078.","journal-title":"Reprod Fertil"},{"issue":"6","key":"1977_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.17691\/stm2020.12.6.07","volume":"12","author":"DV Melnikov","year":"2021","unstructured":"Melnikov DV, Kirillova KA, Zakharenko AS, et al. Effect of Cryo-Processing on Platelet-Rich autoplasma preparations. Sovrem Tekhnologii Med. 2021;12(6):54\u201360. https:\/\/doi.org\/10.17691\/stm2020.12.6.07.","journal-title":"Sovrem Tekhnologii Med"},{"issue":"5","key":"1977_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ajog.2023.01.018","volume":"228","author":"M Marchante","year":"2023","unstructured":"Marchante M, Buigues A, Ramirez-Martin N, et al. Single intraovarian dose of stem cell- and platelet-secreted factors mitigates age-related ovarian infertility in a murine model. Am J Obstet Gynecol. 2023;228(5):561. .e1-561.e17.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"1977_CR29","doi-asserted-by":"publisher","first-page":"e2404295","DOI":"10.1002\/adhm.202404295","volume":"14","author":"X Shi","year":"2025","unstructured":"Shi X, Wang Z, Bi Z, Liu J, Zhang P. Enhancing Immunomodulation and osseointegration of bone implants via Thrombin-Activated Platelet-Rich plasma Self-Assembly. Adv Healthc Mater. 2025;14(9):e2404295. https:\/\/doi.org\/10.1002\/adhm.202404295.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"1977_CR30","doi-asserted-by":"publisher","first-page":"18428","DOI":"10.1038\/s41598-023-45747-3","volume":"13","author":"J Tian","year":"2023","unstructured":"Tian J, Li XJ, Ma Y, et al. Correlation of bioactive components of platelet rich plasma derived from human female adult peripheral blood and umbilical cord blood with age. Sci Rep. 2023;13(1):18428. https:\/\/doi.org\/10.1038\/s41598-023-45747-3.","journal-title":"Sci Rep"},{"issue":"2","key":"1977_CR31","doi-asserted-by":"publisher","first-page":"2287705","DOI":"10.1080\/07853890.2023.2287705","volume":"55","author":"Y Hou","year":"2023","unstructured":"Hou Y, Wen X, Zhou L, Fang X. The value of platelet-rich plasma-derived extracellular vesicles in modern medicine. Ann Med. 2023;55(2):2287705. https:\/\/doi.org\/10.1080\/07853890.2023.2287705.","journal-title":"Ann Med"},{"issue":"11","key":"1977_CR32","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/jbm.a.37579","volume":"111","author":"E Anitua","year":"2023","unstructured":"Anitua E, Zalduendo M, Troya M, Tierno R, Alkhraisat MH. Cellular composition modifies the biological properties and stability of platelet rich plasma membranes for tissue engineering. J Biomed Mater Res A. 2023;111(11):1710\u201321. https:\/\/doi.org\/10.1002\/jbm.a.37579.","journal-title":"J Biomed Mater Res A"},{"issue":"1","key":"1977_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13048-025-01667-6","volume":"18","author":"E Anitua","year":"2025","unstructured":"Anitua E, de la Fuente M, Prado R, Alkhraisat MH. Platelet-rich plasma activation: are there differential effects in reproductive medicine? J Ovarian Res. 2025;18(1):84. https:\/\/doi.org\/10.1186\/s13048-025-01667-6.","journal-title":"J Ovarian Res"},{"issue":"Pt 1","key":"1977_CR34","doi-asserted-by":"publisher","first-page":"129850","DOI":"10.1016\/j.ijbiomac.2024.129850","volume":"262","author":"R Mani","year":"2024","unstructured":"Mani R, Roopmani P, Rajendran J, Maharana S, Giri J. Cord blood platelet rich plasma (PRP) as a potential alternative to autologous PRP for allogenic Preparation and regenerative applications. Int J Biol Macromol. 2024;262(Pt 1):129850. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129850.","journal-title":"Int J Biol Macromol"},{"key":"1977_CR35","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.reth.2024.09.006","volume":"26","author":"W Liu","year":"2024","unstructured":"Liu W, Liu Y, Li T, et al. Long-term stability of frozen platelet-rich plasma under \u2013\u200980\u00b0C storage condition. Regen Ther. 2024;26:826\u201330. https:\/\/doi.org\/10.1016\/j.reth.2024.09.006.","journal-title":"Regen Ther"},{"key":"1977_CR36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.reth.2024.03.021","volume":"27","author":"R Nakajima","year":"2024","unstructured":"Nakajima R, Saita Y, Kobayashi Y, et al. Comparison of bioactive substances in novel-developed freeze-dried platelet-rich plasma (PRP) and activated normal PRP, and investigation of bioactive substance levels after long-term storage. Regen Ther. 2024;27:200\u20136. https:\/\/doi.org\/10.1016\/j.reth.2024.03.021.","journal-title":"Regen Ther"},{"issue":"4","key":"1977_CR37","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/ijms21041328","volume":"21","author":"E Mariani","year":"2020","unstructured":"Mariani E, Pulsatelli L. Platelet concentrates in musculoskeletal medicine. Int J Mol Sci. 2020;21(4):1328. https:\/\/doi.org\/10.3390\/ijms21041328.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1977_CR38","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1055\/s-0043-1770962","volume":"39","author":"D Patel","year":"2023","unstructured":"Patel D, Tatum SA. Bone graft substitutes and enhancement in craniomaxillofacial surgery. Facial Plast Surg. 2023;39(5):556\u201363. https:\/\/doi.org\/10.1055\/s-0043-1770962.","journal-title":"Facial Plast Surg"},{"key":"1977_CR39","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.reth.2025.06.008","volume":"30","author":"FMA Altalbawy","year":"2025","unstructured":"Altalbawy FMA, Mukhlif BAM, Hussen A, et al. Regenerative potential of PRP-based scaffolds in chronic wound healing: Mechanisms, advances, and therapeutic insights. Regen Ther. 2025;30:278\u201398. https:\/\/doi.org\/10.1016\/j.reth.2025.06.008.","journal-title":"Regen Ther"},{"key":"1977_CR40","doi-asserted-by":"publisher","unstructured":"Xie M, Zhao B, Teng J et al. Effect of Fixed-Angle and horizontal rotor centrifugation on optimized Platelet-Rich plasma Preparation. Aesthetic plast Surg. Published online 2025 Jun 2. https:\/\/doi.org\/10.1007\/s00266-025-04941-6","DOI":"10.1007\/s00266-025-04941-6"},{"issue":"Suppl 1","key":"1977_CR41","doi-asserted-by":"publisher","first-page":"S607","DOI":"10.4103\/jpbs.JPBS_163_20","volume":"12","author":"VR Srinivasan","year":"2020","unstructured":"Srinivasan VR, Rekha M, Edsor E, Raja SP, Kumar TD, Kalaiselvan S. Assessment of quality of Platelet-Rich plasma produced with desktop centrifuge and comparison with standardized commercially available Platelet-rich plasma. J Pharm Bioallied Sci. 2020;12(Suppl 1):S607\u201312. https:\/\/doi.org\/10.4103\/jpbs.JPBS_163_20.","journal-title":"J Pharm Bioallied Sci"},{"issue":"11","key":"1977_CR42","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1055\/a-1790-7982","volume":"43","author":"Y Peng","year":"2022","unstructured":"Peng Y, Guanglan W, Jia S, Zheng C. Leukocyte-rich and Leukocyte-poor Platelet-rich plasma in rotator cuff repair: A Meta-analysis. Int J Sports Med. 2022;43(11):921\u201330. https:\/\/doi.org\/10.1055\/a-1790-7982.","journal-title":"Int J Sports Med"},{"issue":"14","key":"1977_CR43","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.3390\/ijms21144982","volume":"21","author":"P Gentile","year":"2020","unstructured":"Gentile P, Garcovich S. Systematic Review\u2014The potential regenerative role of Platelet-Rich plasma (PRP) in the treatment of female androgenetic alopecia. Int J Mol Sci. 2020;21(14):4982. https:\/\/doi.org\/10.3390\/ijms21144982.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1977_CR44","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00404-020-05570-1","volume":"302","author":"A Maleki-Hajiagha","year":"2020","unstructured":"Maleki-Hajiagha A, Razavi M, Rouholamin S, Rezaeinejad M, Maroufizadeh S, Sepidarkish M. Intraovarian infusion of platelet-rich plasma before ART and pregnancy outcomes: a systematic review and meta-analysis. Arch Gynecol Obstet. 2020;302(2):315\u201323. https:\/\/doi.org\/10.1007\/s00404-020-05570-1.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"1977_CR45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12958-021-00815-0","volume":"19","author":"L Nazari","year":"2021","unstructured":"Nazari L, Salehpour S, Hosseini L, et al. Autologous platelet-rich plasma ovarian rejuvenation in women with physiological or pathological ovarian insufficiency: a narrative review. Reprod Biol Endocrinol. 2021;19(1):124. https:\/\/doi.org\/10.1186\/s12958-021-00815-0.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"1977_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000510419","volume":"86","author":"K Sfakianoudis","year":"2021","unstructured":"Sfakianoudis K, Simopoulou M, Nitsos N, et al. A case series on Platelet-Rich plasma revolutionary management of poor responder patients. Gynecol Obstet Invest. 2021;86(1):79\u201385. https:\/\/doi.org\/10.1159\/000510419.","journal-title":"Gynecol Obstet Invest"},{"issue":"11","key":"1977_CR47","doi-asserted-by":"publisher","first-page":"e05415","DOI":"10.1016\/j.heliyon.2020.e05415","volume":"6","author":"M Farimani","year":"2020","unstructured":"Farimani M, Heshmati S, Poorolajal J, Bahmanzadeh M. Adjuvant intra-ovarian injection of autologous platelet-rich plasma in women with poor ovarian response undergoing in vitro fertilization: A randomized clinical trial. Heliyon. 2020;6(11):e05415. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e05415.","journal-title":"Heliyon"},{"key":"1977_CR48","doi-asserted-by":"publisher","unstructured":"Petryk N, Petryk M. In vitro fertilization in women with diminished ovarian reserve: A randomized controlled trial on the use of autologous Platelet-Rich plasma intraovarian infusion. Int J Reprod Med. 2020;8684730. https:\/\/doi.org\/10.1155\/2020\/8684730.","DOI":"10.1155\/2020\/8684730"},{"issue":"11","key":"1977_CR49","doi-asserted-by":"publisher","first-page":"10211","DOI":"10.18632\/aging.103493","volume":"12","author":"Y Cakiroglu","year":"2020","unstructured":"Cakiroglu Y, Saltik A, Yuceturk A, Karaosmanoglu O, Kopuk SY, Scott RT Jr. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging. 2020;12(11):10211\u201322. https:\/\/doi.org\/10.18632\/aging.103493.","journal-title":"Aging"},{"issue":"11","key":"1977_CR50","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1007\/s10815-020-01946-3","volume":"37","author":"K Pantos","year":"2020","unstructured":"Pantos K, Nitsos N, Kokkali G, et al. Intraovarian autologous platelet-rich plasma as a potential strategy for treating premature ovarian insufficiency and poor ovarian response: A narrative review. J Assist Reprod Genet. 2020;37(11):2637\u201345. https:\/\/doi.org\/10.1007\/s10815-020-01946-3.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"1977_CR51","first-page":"59","volume":"22","author":"R Fl\u00f6ck","year":"2021","unstructured":"Fl\u00f6ck R. Application of Platelet-Rich plasma in fertility treatment: A review of current findings. J Reprod Infertil. 2021;22(2):59\u201366.","journal-title":"J Reprod Infertil"},{"issue":"1","key":"1977_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-022-00981-9","volume":"15","author":"R Khan","year":"2022","unstructured":"Khan R, Han T, Zhen Q, et al. Intra-ovarian injection of platelet-rich plasma improves the outcomes of assisted reproductive technology cycles in women with low ovarian reserve: A retrospective study. J Ovarian Res. 2022;15(1):1\u20139. https:\/\/doi.org\/10.1186\/s13048-022-00981-9.","journal-title":"J Ovarian Res"},{"issue":"1","key":"1977_CR53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12958-021-00827-w","volume":"19","author":"M Farimani","year":"2021","unstructured":"Farimani M, Poorolajal J, Heshmati S, Bahmanzadeh M. Intraovarian infusion of autologous platelet-rich plasma improves ovarian reserve and pregnancy outcomes in women with poor ovarian response: A double-blind randomized clinical trial. Reprod Biol Endocrinol. 2021;19(1):139. https:\/\/doi.org\/10.1186\/s12958-021-00827-w.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"1977_CR54","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5653\/cerm.2022.04978","volume":"49","author":"M Stojkovic","year":"2022","unstructured":"Stojkovic M, Dzafic E, Tomic V, et al. The influence of autologous platelet-rich plasma injection into ovarian tissue on pregnancy rate and ovarian function in women with diminished ovarian reserve. Clin Exp Reprod Med. 2022;49(1):46\u201351. https:\/\/doi.org\/10.5653\/cerm.2022.04978.","journal-title":"Clin Exp Reprod Med"},{"issue":"4","key":"1977_CR55","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s10815-021-02375-1","volume":"39","author":"A Makrigiannakis","year":"2022","unstructured":"Makrigiannakis A, Vrekoussis T, Panagopoulos P, et al. Intraovarian infusion of platelet-rich plasma improves ovarian function and pregnancy outcomes in women with poor ovarian reserve. J Assist Reprod Genet. 2022;39(4):833\u201341. https:\/\/doi.org\/10.1007\/s10815-021-02375-1.","journal-title":"J Assist Reprod Genet"},{"issue":"17","key":"1977_CR56","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.3390\/jcm10173922","volume":"10","author":"A Domaradzka","year":"2021","unstructured":"Domaradzka A, Radwan P, Modzelewska B, Radwan M. Autologous Platelet-Rich plasma (PRP) as a treatment for ovarian insufficiency: A systematic review. J Clin Med. 2021;10(17):3922. https:\/\/doi.org\/10.3390\/jcm10173922.","journal-title":"J Clin Med"},{"issue":"2","key":"1977_CR57","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1055\/a-1227-4747","volume":"81","author":"N Kossack","year":"2021","unstructured":"Kossack N, Fritsch M, Hausler A. Platelet-rich plasma (PRP) in gynecology and reproductive medicine: A review of the literature. Geburtshilfe Frauenheilkd. 2021;81(2):186\u201394. https:\/\/doi.org\/10.1055\/a-1227-4747.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"3","key":"1977_CR58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/jhrs.JHRS_51_20","volume":"13","author":"SR Tandulwadkar","year":"2020","unstructured":"Tandulwadkar SR, Naralkar M, Surana A, Selvakarthick M, Kharat A. Autologous platelet-rich plasma for ovarian rejuvenation. J Hum Reprod Sci. 2020;13(3):195\u20139. https:\/\/doi.org\/10.4103\/jhrs.JHRS_51_20.","journal-title":"J Hum Reprod Sci"},{"issue":"6","key":"1977_CR59","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3390\/jcm9061809","volume":"9","author":"K Sfakianoudis","year":"2020","unstructured":"Sfakianoudis K, Simopoulou M, Giannelou P, et al. Autologous platelet-rich plasma for the treatment of premature ovarian insufficiency and poor ovarian response: A prospective pilot study. J Clin Med. 2020;9(6):1809. https:\/\/doi.org\/10.3390\/jcm9061809.","journal-title":"J Clin Med"},{"key":"1977_CR60","doi-asserted-by":"publisher","first-page":"144","DOI":"10.11604\/pamj.2020.35.144.23192","volume":"35","author":"A Al-Baghdadi","year":"2020","unstructured":"Al-Baghdadi A. Autologous intraovarian injection of platelet-rich plasma for ovarian rejuvenation. Pan Afr Med J. 2020;35:144. https:\/\/doi.org\/10.11604\/pamj.2020.35.144.23192.","journal-title":"Pan Afr Med J"},{"issue":"4","key":"1977_CR61","first-page":"1524","volume":"10","author":"JS Shah","year":"2021","unstructured":"Shah JS, Patel SS, Shah SM, Patel BG, Venkatakrishnan R. Autologous Platelet-Rich plasma intraovarian injection for the management of poor ovarian reserve: A clinical study. Int J Reprod Contracept Obstet Gynecol. 2021;10(4):1524\u20139.","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"issue":"1","key":"1977_CR62","first-page":"1","volume":"26","author":"ME Ghanem","year":"2021","unstructured":"Ghanem ME, Helmy YA. The impact of intra-ovarian autologous platelet-rich plasma injection on ovarian reserve and pregnancy rate among poor responder females undergoing IVF: A randomized controlled trial. Middle East Fertil Soc J. 2021;26(1):1\u20137.","journal-title":"Middle East Fertil Soc J"},{"issue":"3","key":"1977_CR63","first-page":"e74","volume":"114","author":"M Rizk","year":"2020","unstructured":"Rizk M, AbouSelhami M, Mosbah A, et al. Effect of autologous platelet-rich plasma on ovarian reserve markers in patients with poor ovarian response: a randomized clinical trial. Fertil Steril. 2020;114(3):e74.","journal-title":"Fertil Steril"},{"issue":"1","key":"1977_CR64","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12958-022-00930-8","volume":"20","author":"I Virant-Klun","year":"2022","unstructured":"Virant-Klun I. Platelet-Rich plasma as a potential strategy for ovarian rejuvenation: clinical insights and molecular mechanisms. Reprod Biol Endocrinol. 2022;20(1):20. https:\/\/doi.org\/10.1186\/s12958-022-00930-8.","journal-title":"Reprod Biol Endocrinol"},{"issue":"8","key":"1977_CR65","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1111\/jog.15331","volume":"48","author":"M Karimi-Zarchi","year":"2022","unstructured":"Karimi-Zarchi M, Nezhad MHK, Yavari A, et al. Autologous platelet-rich plasma intraovarian infusion and its effect on ovarian function and pregnancy outcome: a systematic review and meta-analysis. J Obstet Gynaecol Res. 2022;48(8):1870\u201382. https:\/\/doi.org\/10.1111\/jog.15331.","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"1977_CR66","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/jcm10051104","volume":"10","author":"K Sfakianoudis","year":"2021","unstructured":"Sfakianoudis K, Simopoulou M, Rapani A, et al. Autologous Platelet-Rich plasma treatment enables pregnancy for a woman in early menopause. J Clin Med. 2021;10(5):1104. https:\/\/doi.org\/10.3390\/jcm10051104.","journal-title":"J Clin Med"},{"issue":"1","key":"1977_CR67","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12905-021-01265-w","volume":"21","author":"ME Gonzalez-Gonzalez","year":"2021","unstructured":"Gonzalez-Gonzalez ME, Pascual-Mu\u00f1oz MP, Ram\u00edrez-N\u00fa\u00f1ez M, et al. Platelet-rich plasma intraovarian infusion in assisted reproductive technology: A pilot study. BMC Womens Health. 2021;21(1):123. https:\/\/doi.org\/10.1186\/s12905-021-01265-w.","journal-title":"BMC Womens Health"},{"issue":"1","key":"1977_CR68","first-page":"1","volume":"25","author":"H Al-Inany","year":"2020","unstructured":"Al-Inany H, Zaki A. Intraovarian platelet-rich plasma: A hope for women with diminished ovarian reserve. Middle East Fertil Soc J. 2020;25(1):1\u20133.","journal-title":"Middle East Fertil Soc J"},{"issue":"4","key":"1977_CR69","first-page":"1063","volume":"37","author":"N Ahmad","year":"2021","unstructured":"Ahmad N, Ahmed A, Shami Z, Ali T. Role of PRP in patients with poor ovarian reserve undergoing IVF. Pak J Med Sci. 2021;37(4):1063\u20137.","journal-title":"Pak J Med Sci"},{"issue":"1","key":"1977_CR70","first-page":"1","volume":"26","author":"Y Nurelhuda","year":"2021","unstructured":"Nurelhuda Y, Abdelrahman AA, El-Sayed H, El-Mazny A. Platelet-rich plasma ovarian injection improves ovarian function and pregnancy outcome in women with diminished ovarian reserve. Middle East Fertil Soc J. 2021;26(1):1\u20136.","journal-title":"Middle East Fertil Soc J"},{"issue":"1","key":"1977_CR71","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12958-020-00624-8","volume":"18","author":"ES Sills","year":"2020","unstructured":"Sills ES, Wood SH. Autologous activated platelet-rich plasma injection into human ovarian tissue: clinical response in a series of women with poor ovarian reserve. Reprod Biol Endocrinol. 2020;18(1):80. https:\/\/doi.org\/10.1186\/s12958-020-00624-8.","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"1977_CR72","first-page":"996","volume":"41","author":"K Sfakianoudis","year":"2020","unstructured":"Sfakianoudis K, Simopoulou M, Nikolettos K, et al. Autologous platelet-rich plasma infusion inside the ovarian cortex in a patient with poor ovarian reserve. Reprod Biomed Online. 2020;41(6):996\u20131003.","journal-title":"Reprod Biomed Online"},{"key":"1977_CR73","first-page":"24","volume":"261","author":"L Mamas","year":"2021","unstructured":"Mamas L, Kolibianakis E, Xepapadaki E, et al. Intra-ovarian PRP administration in women with POI: A case series. Eur J Obstet Gynecol Reprod Biol. 2021;261:24\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"1977_CR74","first-page":"113","volume":"23","author":"E Ahmadi","year":"2022","unstructured":"Ahmadi E, Fadaei R, Khalilzadeh S, et al. Evaluation of Intra-ovarian platelet rich plasma administration for ovarian rejuvenation in poor responder patients: A clinical trial. J Reprod Infertil. 2022;23(2):113\u201320.","journal-title":"J Reprod Infertil"},{"issue":"3","key":"1977_CR75","first-page":"155","volume":"21","author":"F Mehrabian","year":"2023","unstructured":"Mehrabian F, Aflatoonian A, Khosravi F, et al. Intraovarian infusion of autologous PRP in ART cycles: A randomized controlled trial. Iran J Reprod Med. 2023;21(3):155\u201362.","journal-title":"Iran J Reprod Med"},{"issue":"2","key":"1977_CR76","first-page":"132","volume":"18","author":"B Haydardedeoglu","year":"2021","unstructured":"Haydardedeoglu B, Ceyhan ST, Yildiz EA, et al. The effect of intraovarian PRP injection on ovarian reserve markers: A prospective study. Turk J Obstet Gynecol. 2021;18(2):132\u20137.","journal-title":"Turk J Obstet Gynecol"},{"issue":"2","key":"1977_CR77","first-page":"84","volume":"9","author":"L Hosseini","year":"2022","unstructured":"Hosseini L, Shahraki H, Ghasemi-Esmailabad S, et al. Ovarian rejuvenation with PRP in women with age-related infertility: A clinical report. Fertil Sci Res. 2022;9(2):84\u20139.","journal-title":"Fertil Sci Res"},{"issue":"4","key":"1977_CR78","first-page":"345","volume":"25","author":"M Babaei","year":"2022","unstructured":"Babaei M, Bahmanzadeh M. PRP infusion in IVF cycles: A novel approach to improve ovarian response. J Hum Fertil. 2022;25(4):345\u201351.","journal-title":"J Hum Fertil"},{"issue":"7","key":"1977_CR79","first-page":"593","volume":"19","author":"S Zadehmodarres","year":"2021","unstructured":"Zadehmodarres S, Nazari L, Salehpour S, et al. PRP in women with thin endometrium and poor ovarian response: outcomes from a controlled trial. Int J Reprod BioMed. 2021;19(7):593\u2013600.","journal-title":"Int J Reprod BioMed"},{"issue":"7","key":"1977_CR80","first-page":"880","volume":"13","author":"D Mehrabani","year":"2021","unstructured":"Mehrabani D, Tayebi L, Barzegar K, et al. Application of platelet-rich plasma in female reproductive system disorders. World J Stem Cells. 2021;13(7):880\u201398.","journal-title":"World J Stem Cells"},{"issue":"1","key":"1977_CR81","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12958-021-00880-4","volume":"20","author":"M Shahbazi","year":"2022","unstructured":"Shahbazi M, Ghaffari Novin M, Shariat M, et al. PRP in assisted reproduction: systematic review and future recommendations. Reprod Biol Endocrinol. 2022;20(1):5.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"1977_CR82","first-page":"315","volume":"158","author":"I Elnashar","year":"2022","unstructured":"Elnashar I, Farid E, Abdel-Khalek A. Comparison between PRP and G-CSF for improving ovarian reserve: A randomized trial. Int J Gynaecol Obstet. 2022;158(2):315\u201321.","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"1977_CR83","first-page":"334","volume":"87","author":"M Samavarchi-Tehrani","year":"2022","unstructured":"Samavarchi-Tehrani M, Shojaei M, Moein M. Application of regenerative medicine in gynecology: PRP and stem cells. Gynecol Obstet Invest. 2022;87(4):334\u201342.","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"1977_CR84","first-page":"e12563","volume":"22","author":"K Sfakianoudis","year":"2023","unstructured":"Sfakianoudis K, Simopoulou M. PRP-based therapies in poor ovarian response: clinical practice update. Reprod Med Biol. 2023;22(1):e12563.","journal-title":"Reprod Med Biol"},{"key":"1977_CR85","doi-asserted-by":"publisher","first-page":"CD013875","DOI":"10.1002\/14651858.CD013875.pub2","volume":"4","author":"D Vaidakis","year":"2024","unstructured":"Vaidakis D, Papapanou M, Siristatidis CS. Autologous platelet-rich plasma for assisted reproduction. Cochrane Database Syst Rev. 2024;4:CD013875. https:\/\/doi.org\/10.1002\/14651858.CD013875.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1977_CR86","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.4314\/ejhs.v32i6.10","volume":"32","author":"F Keikha","year":"2022","unstructured":"Keikha F, Shahsavari S, Salari Y, et al. One side ovarian rejuvenation: A Quasi-Experimental study of the effect of the autologous platelet rich plasma in poor ovarian responders in IVF. Ethiop J Health Sci. 2022;32(6):1133\u201340. https:\/\/doi.org\/10.4314\/ejhs.v32i6.10.","journal-title":"Ethiop J Health Sci"},{"issue":"1","key":"1977_CR87","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12958-021-00826-w","volume":"19","author":"M Farimani","year":"2021","unstructured":"Farimani M, Nazari A, Mohammadi S, Anvari Aliabad R. Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria. Reprod Biol Endocrinol. 2021;19(1):137. https:\/\/doi.org\/10.1186\/s12958-021-00826-w.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"1977_CR88","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12905-024-03101-3","volume":"24","author":"W Li","year":"2024","unstructured":"Li W, Xu J, Deng D. The effect of ovarian response parameters and the synergistic effect of assisted reproduction of poor ovarian response treated with platelet rich plasma: systematic review and meta-analysis. BMC Womens Health. 2024;24(1):263. https:\/\/doi.org\/10.1186\/s12905-024-03101-3.","journal-title":"BMC Womens Health"},{"issue":"11","key":"1977_CR89","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s43032-020-00266-8","volume":"27","author":"N Petryk","year":"2020","unstructured":"Petryk N, Petryk M. Ovarian rejuvenation through Platelet-Rich autologous plasma (PRP)-a chance to have a baby without donor Eggs, improving the life quality of women suffering from early menopause without synthetic hormonal treatment. Reprod Sci. 2020;27(11):1975\u201382. https:\/\/doi.org\/10.1007\/s43032-020-00266-8.","journal-title":"Reprod Sci"},{"key":"1977_CR90","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fendo.2020.00050","volume":"11","author":"CC Hsu","year":"2020","unstructured":"Hsu CC, Hsu L, Hsu I, Chiu YJ, Dorjee S. Live birth in woman with premature ovarian insufficiency receiving ovarian administration of Platelet-Rich plasma (PRP) in combination with gonadotropin: A case report. Front Endocrinol (Lausanne). 2020;11:50. https:\/\/doi.org\/10.3389\/fendo.2020.00050.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1977_CR91","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13048-024-01423-2","volume":"17","author":"M \u00c9li\u00e1s","year":"2024","unstructured":"\u00c9li\u00e1s M, K\u00f3nya M, Kekk Z, et al. Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: a systematic review and meta-analysis. J Ovarian Res. 2024;17(1):104. https:\/\/doi.org\/10.1186\/s13048-024-01423-2.","journal-title":"J Ovarian Res"},{"issue":"5","key":"1977_CR92","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2174\/1566523220666200928142333","volume":"20","author":"W Jiao","year":"2020","unstructured":"Jiao W, Mi X, Qin Y, Zhao S. Stem cell transplantation improves ovarian function through paracrine mechanisms. Curr Gene Ther. 2020;20(5):347\u201355. https:\/\/doi.org\/10.2174\/1566523220666200928142333.","journal-title":"Curr Gene Ther"},{"issue":"8","key":"1977_CR93","doi-asserted-by":"publisher","first-page":"857","DOI":"10.4252\/wjsc.v12.i8.857","volume":"12","author":"K Bahrehbar","year":"2020","unstructured":"Bahrehbar K, Rezazadeh Valojerdi M, Esfandiari F, Fathi R, Hassani SN, Baharvand H. Human embryonic stem cell-derived mesenchymal stem cells improved premature ovarian failure. World J Stem Cells. 2020;12(8):857\u201378. https:\/\/doi.org\/10.4252\/wjsc.v12.i8.857.","journal-title":"World J Stem Cells"},{"issue":"12","key":"1977_CR94","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3390\/life13122247","volume":"13","author":"YO Martirosyan","year":"2023","unstructured":"Martirosyan YO, Silachev DN, Nazarenko TA, Birukova AM, Vishnyakova PA, Sukhikh GT. Stem-Cell-Derived extracellular vesicles: unlocking new possibilities for treating diminished ovarian reserve and premature ovarian insufficiency. Life (Basel). 2023;13(12):2247. https:\/\/doi.org\/10.3390\/life13122247.","journal-title":"Life (Basel)"},{"key":"1977_CR95","doi-asserted-by":"publisher","first-page":"5045873","DOI":"10.1155\/2022\/5045873","volume":"2022","author":"T Gao","year":"2022","unstructured":"Gao T, Cao Y, Hu M, Du Y. Human umbilical cord mesenchymal stem Cell-Derived extracellular vesicles carrying MicroRNA-29a improves ovarian function of mice with primary ovarian insufficiency by targeting HMG-Box transcription Factor\/Wnt\/\u03b2-Catenin signaling. Dis Markers. 2022;2022:5045873. https:\/\/doi.org\/10.1155\/2022\/5045873.","journal-title":"Dis Markers"},{"issue":"5","key":"1977_CR96","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/humupd\/dmae020","volume":"30","author":"Y Guo","year":"2024","unstructured":"Guo Y, Xue L, Tang W, et al. Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage. Hum Reprod Update. 2024;30(5):614\u201347. https:\/\/doi.org\/10.1093\/humupd\/dmae020.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1977_CR97","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s13287-024-04111-6","volume":"15","author":"Q Qu","year":"2024","unstructured":"Qu Q, Liu L, Wang L, et al. Exosomes derived from hypoxic mesenchymal stem cells restore ovarian function by enhancing angiogenesis. Stem Cell Res Ther. 2024;15(1):496. https:\/\/doi.org\/10.1186\/s13287-024-04111-6.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1977_CR98","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13048-025-01778-0","volume":"18","author":"S Yimamuyushan","year":"2025","unstructured":"Yimamuyushan S, Shi S, Muheremu A, Yi J. PEDF-Expressing mesenchymal stem cells restore ovarian function via Tim-3-Mediated immune modulation in primary ovarian failure. J Ovarian Res. 2025;18(1):182. https:\/\/doi.org\/10.1186\/s13048-025-01778-0.","journal-title":"J Ovarian Res"},{"issue":"1","key":"1977_CR99","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13287-024-03660-0","volume":"15","author":"J Shen","year":"2024","unstructured":"Shen J, Wu L, Shi X, et al. Transplantation of the LRP1high subpopulation of human umbilical cord-derived mesenchymal stem cells improves ovarian function in mice with premature ovarian failure and aged mice. Stem Cell Res Ther. 2024;15(1):64. https:\/\/doi.org\/10.1186\/s13287-024-03660-0.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1977_CR100","doi-asserted-by":"publisher","first-page":"113689","DOI":"10.1016\/j.yexcr.2023.113689","volume":"430","author":"M Saber","year":"2023","unstructured":"Saber M, Shekari F, Mousavi SA, Moini A, Miri MS, Esfandiari F. JAK\/STAT3 pathway promotes proliferation of ovarian aggregate-derived stem cells in vitro. Exp Cell Res. 2023;430(1):113689. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113689.","journal-title":"Exp Cell Res"},{"issue":"4","key":"1977_CR101","doi-asserted-by":"publisher","first-page":"hoad040","DOI":"10.1093\/hropen\/hoad040","volume":"2023","author":"L Cacciottola","year":"2023","unstructured":"Cacciottola L, Vitale F, Donnez J, Dolmans MM. Use of mesenchymal stem cells to enhance or restore fertility potential: a systematic review of available experimental strategies. Hum Reprod Open. 2023;2023(4):hoad040. https:\/\/doi.org\/10.1093\/hropen\/hoad040.","journal-title":"Hum Reprod Open"},{"issue":"7","key":"1977_CR102","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1007\/s43032-025-01854-2","volume":"32","author":"L Liu","year":"2025","unstructured":"Liu L, Fang Y. The role of ovarian granulosa cells Related-ncRNAs in ovarian dysfunctions: mechanism research and clinical exploration. Reprod Sci. 2025;32(7):2098\u2013120. https:\/\/doi.org\/10.1007\/s43032-025-01854-2.","journal-title":"Reprod Sci"},{"issue":"12","key":"1977_CR103","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1007\/s43032-024-01523-w","volume":"31","author":"S Xiao","year":"2024","unstructured":"Xiao S, Du J, Yuan G, Luo X, Song L. Granulosa Cells-Related MicroRNAs in ovarian diseases: Mechanism, facts and perspectives. Reprod Sci. 2024;31(12):3635\u201350. https:\/\/doi.org\/10.1007\/s43032-024-01523-w.","journal-title":"Reprod Sci"},{"issue":"1","key":"1977_CR104","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s40001-023-01231-2","volume":"28","author":"M Liu","year":"2023","unstructured":"Liu M, Xiao B, Zhu Y, et al. MicroRNA-144-3p protects against chemotherapy-induced apoptosis of ovarian granulosa cells and activation of primordial follicles by targeting MAP3K9. Eur J Med Res. 2023;28(1):264. https:\/\/doi.org\/10.1186\/s40001-023-01231-2.","journal-title":"Eur J Med Res"},{"issue":"2","key":"1977_CR105","doi-asserted-by":"publisher","first-page":"e70074","DOI":"10.1002\/mgg3.70074","volume":"13","author":"H Gao","year":"2025","unstructured":"Gao H, Cao XX, Hua H, Zhu H. The functions and implications of MicroRNAs in premature ovarian insufficiency. Mol Genet Genomic Med. 2025;13(2):e70074. https:\/\/doi.org\/10.1002\/mgg3.70074.","journal-title":"Mol Genet Genomic Med"},{"issue":"23","key":"1977_CR106","doi-asserted-by":"publisher","first-page":"12979","DOI":"10.3390\/ijms252312979","volume":"25","author":"L Chico-Sordo","year":"2024","unstructured":"Chico-Sordo L, Garc\u00eda-Velasco JA. MicroRNAs as biomarkers and therapeutic targets in female infertility. Int J Mol Sci. 2024;25(23):12979. https:\/\/doi.org\/10.3390\/ijms252312979.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1977_CR107","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12958-024-01277-9","volume":"22","author":"Z Liu","year":"2024","unstructured":"Liu Z, Zhou Q, He L, et al. Identification of energy metabolism anomalies and serum biomarkers in the progression of premature ovarian failure via extracellular vesicles\u2019proteomic and metabolomic profiles. Reprod Biol Endocrinol. 2024;22(1):104. https:\/\/doi.org\/10.1186\/s12958-024-01277-9.","journal-title":"Reprod Biol Endocrinol"},{"issue":"5","key":"1977_CR108","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3390\/ijms26052317","volume":"26","author":"T vaskiene","year":"2025","unstructured":"vaskiene T, Kaspute G, Bareikiene E, Prentice U. Platelet-Rich plasma and electrochemical biosensors: A novel approach to ovarian function evaluation and diagnostics. Int J Mol Sci. 2025;26(5):2317. https:\/\/doi.org\/10.3390\/ijms26052317.","journal-title":"Int J Mol Sci"},{"key":"1977_CR109","doi-asserted-by":"publisher","first-page":"998424","DOI":"10.3389\/fphys.2022.998424","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Sun X, Yang Z, et al. Epigenetic regulation in premature ovarian failure: A literature review. Front Physiol. 2022;13:998424. https:\/\/doi.org\/10.3389\/fphys.2022.998424.","journal-title":"Front Physiol"},{"issue":"1","key":"1977_CR110","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12964-023-01078-4","volume":"21","author":"E Huang","year":"2023","unstructured":"Huang E, Chen L. RNA N6-methyladenosine modification in female reproductive biology and pathophysiology. Cell Commun Signal. 2023;21(1):53. https:\/\/doi.org\/10.1186\/s12964-023-01078-4.","journal-title":"Cell Commun Signal"},{"key":"1977_CR111","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-025-03599-y","author":"B Seyihoglu","year":"2025","unstructured":"Seyihoglu B, Gucuk S, Can A. Cellular therapies in primary ovarian insufficiency and poor ovarian reserve: a systematic review. J Assist Reprod Genet. 2025. https:\/\/doi.org\/10.1007\/s10815-025-03599-y.","journal-title":"J Assist Reprod Genet"},{"key":"1977_CR112","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-606X.25.05656-8","author":"F Costanzi","year":"2025","unstructured":"Costanzi F, Greco E, Fusco S, et al. The impact of platelet-rich plasma infusion in infertile women undergoing assisted reproduction: a systematic umbrella review of the best clinical evidence. Minerva Obstet Gynecol. 2025. https:\/\/doi.org\/10.23736\/S2724-606X.25.05656-8.","journal-title":"Minerva Obstet Gynecol"},{"issue":"1","key":"1977_CR113","doi-asserted-by":"publisher","first-page":"18292","DOI":"10.1038\/s41598-025-02689-2","volume":"15","author":"Q Li","year":"2025","unstructured":"Li Q, Guo JY, Liu JW, et al. Comparative efficacy of single vs. double autologous platelet-rich plasma ovarian injections for improving ovarian response in poor ovarian responders. Sci Rep. 2025;15(1):18292. https:\/\/doi.org\/10.1038\/s41598-025-02689-2.","journal-title":"Sci Rep"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-01977-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-01977-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-01977-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:41:14Z","timestamp":1776336074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-01977-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1977"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-01977-3","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This article does not involve any studies with human participants or animals performed by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}